3rd International Conference
on Cytokine Medicine
A unique two day forum for all specialities
and disciplines with interests in the clinical
and scientific aspects of Cytokine Medicine
CPD accreditation 
 will be applied for
18th - 19th February 2008
The Conference Centre
Kensington Town Hall
LONDON - UK

Programme - 18 February 2008
09.30 – 10.30 Registration and coffee
10.30 – 10.40 Opening remarks
10.40 – 11.40 Scientific Session 1
Emerging Targets and Treatments
            1.1 New molecular targets in chronic inflammation
Professor Iain McInnes
(University of Glasgow)
            1.2 IL-21 in tumour immunotherapy
Professor Silvano Ferrini
(University of Genoa)
11.40 – 11.50 Discussion
11.50 – 12.50 Scientific Session 2
Cytokines in Tissue Pathology
            2.1 Mucosal pathology
Dr Kevin Maloy
(University of Oxford)
            2.2 Neuronal pathology
Dr Emanuel Pinteaux
(University of Manchester)
12.50 – 13.00 Discussion
13.00 – 14.00 LUNCH - exhibition and poster viewing
14.00 – 15.30 Scientific Session 3
Lessons from the Clinic and the Laboratory
            3.1 Insights into disease mechanisms from use of
biologic therapies
Professor Stephen Holgate
(University of Southampton)
            3.2 Cytokines, adipose tissue and inflammation
Professor Jean-Michel Dayer
(Hôpitaux Universitaires, Geneva)
            3.3 The role of cytokines in immunity to tuberculosis
Dr Ulrich Schaible
(London School of Hygiene and Tropical Medicine)
15.30 – 15.40 Discussion
15.40 – 16.10 Tea
16.10 – 17.40 Sponsored Symposium supported by Abbott
17.40 – 18.10 Welcome Reception
Programme - 19 February 2008
09.00 – 09.30 Scientific Session 4
Evaluation and Monitoring of
Cytokine Medicines: Current Issues
            4.1 Assessing the costs and benefits of biologics
Dr Francis Pang
(Takeda Pharmaceuticals)
09.30 – 09.40 Discussion
09.40 – 10.10 Coffee
10.10 – 12.10 Scientific Session 5
Oral Presentations from Submitted Abstracts
12.10 – 13.10 LUNCH - exhibition and poster viewing
13.10 – 14.40 Scientific Session 6
Advancing Concepts in Therapy
            6.1 Treating psoriasis
Professor Jonathan Barker
(King’s College, London)
            6.2 Dendritic cell vaccination therapy
Professor John Isaacs
(University of Newcastle upon Tyne)
            6.3 Small molecule modulators
Professor Paul Peter Tak
(University of Amsterdam)
14.40 – 14.50 Discussion
14.50 – 15.20 Scientific Session 7
Regulating Clinical Trials: Current Issues
            7.1 Safety assessment of biologics
Professor Sir Gordon Duff
(University of Sheffield)
15.20 – 15.30 Discussion
15.30 – 15.40 Closing Remarks
The provisional programme is correct at the time of printing and the Secretariat accepts no responsibility for any changes made at a later date.